Codex-prepared local review · editorial and translation review pending.
GLEI / EVENT
A small human study reports changes in senescent-cell burden
Mayo Clinic announced early clinical observations in people with diabetes-related kidney disease.
A small safety and feasibility study examined a senolytic drug combination and reported changes in markers of senescent-cell burden in human tissue.
The study population had a specific disease. These observations do not establish lifespan extension or justify unsupervised drug use. The archive uses the Mayo Clinic announcement date rather than inventing a treatment approval date.